摘要
高血压和高尿酸血症发病率高、危害大,且二者常合并存在,值得临床人员重视。目前的共识及指南推荐积极控制尿酸和血压水平,但是对于高血压与高尿酸合并存在的患者,如何规范治疗方案,避免药物对合并症的不良影响,目前的指南和共识有原则性的推荐,但缺乏细则。本文对高血压合并高尿酸血症的流行病学及临床危害、高血压合并无症状高尿酸血症的治疗目标值、治疗措施中的共识和争议等进行了文献复习,综述如下。
Hypertension and hyperuricemia often coexist,and have a high incidence and often incur great harm.The current guidelines recommend active control of uric acid and blood pressure levels.But patients with high uric acid and high blood pressure still need detailed guidelines to standardize the treatment to avoid incurring more drug-related side effects.This article reviews the epidemiology and clinical harm,the therapeutic target value,the consensus and controversy on therapeutic treatment of high blood pressure combined with high uric acid.
作者
李远方
崔兆强
LI Yuanfang;CUI Zhaoqiang(Department of Cardiology,Zhongshan Hospital,Fudan University,Shanghai Institute of Cardiovascular Diseases,Shanghai 200032,China)
出处
《中国临床药理学与治疗学》
CAS
CSCD
2022年第4期428-432,共5页
Chinese Journal of Clinical Pharmacology and Therapeutics